GRCL

Gracell Biotechnologies Inc. American Depositary Shares

Delisted

GRCL was delisted on the 21st of February, 2024.

34 hedge funds and large institutions have $75.1M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
12
Reduced
9
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
$55K +$55K +23,600 New
VIA
27
Vident Investment Advisory
Georgia
$47K +$17.3K +7,331 +58%
Jane Street
28
Jane Street
New York
$31K +$31K +13,340 New
Wells Fargo
29
Wells Fargo
California
$22K +$8.37K +3,630 +61%
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$14K +$3.81K +1,649 +37%
Citigroup
31
Citigroup
New York
$8K -$6.99K -3,019 -47%
TRCT
32
Tower Research Capital (TRC)
New York
$5K -$462 -199 -8%
Capital International Investors
33
Capital International Investors
California
-$12.6M -2,093,416 Closed
FM
34
Frazier Management
Washington
-$10M -1,654,938 Closed
Viking Global Investors
35
Viking Global Investors
Connecticut
-$2.97M -491,647 Closed
Victory Capital Management
36
Victory Capital Management
Texas
-$362K -59,910 Closed
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
-$79K -13,054 Closed
UBS Group
38
UBS Group
Switzerland
-$10K -1,635 Closed
EBA
39
Eagle Bay Advisors
New York
-$1K -160 Closed
FPS
40
Fieldpoint Private Securities
Connecticut
-$1K -160 Closed